| 臺大學術典藏 |
2021-01-15T03:48:07Z |
Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil
|
Hsu C.-H.; Yeh K.-H.; Lui L.T.; Lee Y.-C.; Bu C.-F.; HSIU-PO WANG; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:47:46Z |
Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma
|
Kuo S.-H.; Chen L.-T.; Chen C.-L.; Doong S.-L.; Yeh K.-H.; Wu M.-S.; Mao T.-L.; Hsu H.-C.; HSIU-PO WANG; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:47:32Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; HSIU-PO WANG; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C. |
| 臺大學術典藏 |
2021-01-15T03:47:22Z |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment
|
Kuo S.-H.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; Kuo K.-T.; Yeh P.-Y.; Tzeng Y.-S.; HSIU-PO WANG; Hsu P.-N.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:56Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Hsu P.-N.; HSIU-PO WANG; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:52Z |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; Wu M.-S.; Hsu P.-N.; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; HSIU-PO WANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:45Z |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; Wu M.-S.; Tzeng Y.-S.; Tsai H.-J.; HSIU-PO WANG; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:41Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; HSIU-PO WANG; Yeh K.-H.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-15T03:46:35Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; HSIU-PO WANG; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:33Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; HSIU-PO WANG; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:26Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; HSIU-PO WANG; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-15T03:46:23Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; HSIU-PO WANG; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:20Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; HSIU-PO WANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-14T03:09:20Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; KUO-CHIN HUANG; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-14T03:09:19Z |
High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
|
Liang J.-T.; KUO-CHIN HUANG; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-12T12:49:20Z |
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
|
Chen K.-F.; Yeh P.-Y.; Yeh K.-H.; Lu Y.-S.; SHANG-YI HUANG; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-06T03:59:07Z |
Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome
|
Yeh K.H.; Hsieh H.C.; JIH-LUH TANG; Lin M.T.; Yang C.H.; Chen Y.C. |
| 臺大學術典藏 |
2021-01-06T03:59:02Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; JIH-LUH TANG; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:57Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG; Yeh K.-H.; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-06T03:58:16Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Cheng A.-L.; Kuo S.-H.; Yeh Y.-C.; Wang H.-P.; Wang Y.-T.; Lin C.-W.; JIH-LUH TANG; Yao M.; Yeh K.-H.; Ma W.-L. |
| 臺大學術典藏 |
2021-01-05T03:34:26Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Wang Y.-T.; Lin C.-W.; Tang J.-L.; MING YAO; Yeh K.-H.; Ma W.-L.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-04T12:13:12Z |
Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy
|
Yeh K.H.; Cheng A.L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Liu M.-Y.; Cheng A.-L.; Hsu C.-H.; Wang C.-H.; Tang J.-L.; Yeh K.-H.; Kao W.-Y.; Huang M.-C.; Chang M.-C.; HWEI-FANG TIEN; Chao T.-Y.; Lin Z.-Z.; Su I.-J.; Huang C.-L. |
| 國立成功大學 |
2021 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
|
Yoshino, T.;Argil�s, G.;Oki, E.;Martinelli, E.;Taniguchi, H.;Arnold, D.;Mishima, S.;Li, Y.;Smruti, B.K.;Ahn, J.B.;Faud, I.;Chee, Chee C.E.;Yeh, K.-H.;Lin, P.-C.;Chua, Chua C.;Hasbullah, Hasbullah H.H.;Lee, M.A.;Sharma, A.;Sun, Y.;Curigliano, G.;Bando, H.;Lordick, F.;Yamanaka, T.;Tabernero, J.;Baba, E.;Cervantes, A.;Ohtsu, A.;Peters, S.;Ishioka, C.;Pentheroudakis, G. |
| 國立成功大學 |
2021 |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Yeh, K.-H.;Yang, T.-S.;Hsu, T.-C.;Tzu-Liang, Chen W.;Chen, H.-H.;Teng, H.-W.;Lin, B.-W.;Kuan, F.-C.;Chiang, F.-F.;Duann, C.-W.;Li, Y.-S.;Lin, M.-T.;Fiala-Buskies, S.;Ducreux, M.;Wang, J.-Y. |
